XOMA - XOMA Corp
IEX Last Trade
28.86
0 0%
Share volume: 17,169
Last Updated: Mon 23 Dec 2024 03:34:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.45%
PREVIOUS CLOSE
CHG
CHG%
$28.86
-1.96
0.07%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-08 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 154.222 M | 146.131 M | 140.382 M | 133.664 M | 125.661 M | 124.094 M | 234.301 M | 219.420 M | |
| Current Assets | 87.261 M | 79.741 M | 61.253 M | 45.073 M | 38.423 M | 34.505 M | 169.313 M | 146.890 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.551 M | 997.000 K | 3.091 M | 456.000 K | 5.757 M | 776.000 K | 14.698 M | 10.089 M | |
| Short Term Investments | 3.551 M | 997.000 K | 3.091 M | 456.000 K | 5.757 M | 776.000 K | 14.698 M | 10.089 M | |
| Total Receivables | 5.000 K | 16.000 K | 1.000 K | 6.000 K | 901.000 K | 43.000 K | 1.004 M | 3.000 K | |
| Current Cash | 83.705 M | 78.728 M | 58.161 M | 44.611 M | 31.765 M | 33.686 M | 153.451 M | 136.638 M | |
| Total Non-current Assets | 66.961 M | 66.390 M | 79.129 M | 88.591 M | 87.238 M | 89.589 M | 64.988 M | 72.530 M | |
| Property Plant Equipment | 10.000 K | 8.000 K | 7.000 K | 6.000 K | 5.000 K | 5.000 K | 25.000 K | 40.000 K | |
| Other Assets | 66.835 M | 66.309 M | 63.943 M | 73.593 M | 72.515 M | 75.107 M | 58.485 M | 66.110 M | |
| Intangible Assets | 0.000 | 0.000 | 15.150 M | 14.925 M | 14.701 M | 14.477 M | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 154.222 M | 146.131 M | 140.382 M | 133.664 M | 125.661 M | 124.094 M | 234.301 M | 219.420 M | |
| Total liabilities | 19.266 M | 15.806 M | 16.368 M | 19.138 M | 15.537 M | 18.130 M | 145.580 M | 137.079 M | |
| Total current liabilities | 8.424 M | 5.425 M | 6.818 M | 10.094 M | 7.087 M | 10.334 M | 19.499 M | 15.540 M | |
| Accounts Payable | 1.153 M | 985.000 K | 524.000 K | 437.000 K | 740.000 K | 728.000 K | 653.000 K | 1.515 M | |
| Other liabilities | 10.842 M | 10.381 M | 9.550 M | 9.044 M | 8.450 M | 7.796 M | 7.228 M | 6.692 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 5.543 M | 6.144 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 118.518 M | 114.528 M | |
| Other liabilities | 10.842 M | 10.381 M | 9.550 M | 9.044 M | 8.450 M | 7.796 M | 7.228 M | 6.692 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 134.956 M | 130.325 M | 124.014 M | 114.526 M | 110.124 M | 105.964 M | 88.721 M | 82.341 M | |
| Common stock | 11.421 M | 11.447 M | 11.454 M | 11.460 M | 11.466 M | 11.473 M | 11.485 M | 11.580 M | |
| Retained earnings | -1.172 B | -1.176 B | -1.182 B | -1.192 B | -1.198 B | -1.203 B | -1.223 B | -1.232 B |